Organization · Venture Capital
Theodorus Investment Funds
Theodorus Investment Funds is a Belgian venture capital firm that invests in early-stage companies leveraging disruptive technologies, primarily in biotech, medtech, digital, and engineering sectors.
Overview
What Theodorus Investment Funds does
What Theodorus Investment Funds is
Theodorus Investment Funds is a Belgian venture capital firm that invests in early-stage companies leveraging disruptive technologies, primarily in biotech, medtech, digital, and engineering sectors.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2003
- Approximate age
- About 23 years
- Structured capabilities
- Funder
- Last reviewed
- March 18, 2026
Official channels
Find Theodorus Investment Funds elsewhere
Open the official website or a supported primary organization account.
Capability profile
Theodorus Investment Funds as a funder
Investment thesis
Theodorus Investment Funds focuses on early-stage investments in projects utilizing proprietary disruptive technologies, particularly in Biotech, MedTech, Digital, and Engineering applications.
Focus narrative
Theodorus primarily invests in seed and early-stage funding, with investment sizes ranging from €250,000 to €2.5 million per company. The organization emphasizes projects emerging from the Université Libre de Bruxelles (ULB) but is also open to external opportunities. Theodorus IV, launched in October 2018, is dedicated to financing life sciences and high-tech companies, with plans to invest between €500,000 and €2.5 million in approximately twenty companies in Belgium and Canada over the next five years.
Value beyond capital
Theodorus provides not only financial support but also strategic guidance and access to a robust network within the university ecosystem, enhancing the growth potential of its portfolio companies.
Terms and economics
- Typical check
- $250,000–$2,500,000
- Sweet spot
- $1,000,000
Focus and fit
- Stages
- Seed · Growth Equity
- Sectors
- Biotech & Life Sciences
- Regions
- Europe
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 40
- Recorded notable exits
- Euro Heat Pipes, MaSTherCell, and Ogeda
Portfolio context
Notable portfolio companies include: Euro Heat Pipes: A leader in Space Thermal control systems, acquired by Airbus Defence and Space in 2017. MaSTherCell: A service company for the industrialization and production of cell and gene therapies, acquired by Catalent in February 2020. Ogeda: A clinical-stage drug discovery company acquired by Astellas Pharma in April 2017. Other investments span medical devices, biotechnology, and high-tech solutions, with several achieving successful exits.
Common questions
What to know about Theodorus Investment Funds
Upseed classifies Theodorus Investment Funds under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 18, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.